Clinical Trial Update: To Evaluate the Safety and Efficacy of Sofosbuvir and Ribavirin in Patients With HCV (Genotype 3) Related Decompensated Cirrhosis [NA]

View source ↗

Summary

A clinical trial evaluating the safety and efficacy of Sofosbuvir plus Ribavirin in patients with genotype 3 hepatitis C-related decompensated cirrhosis was ter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Liver Cirrhosis

Drugs mentioned

• Ribavirin (ribavirin)
• Sofosbuvir (sofosbuvir)

Snippet

Sponsor: Institute of Liver and Biliary Sciences, India | Conditions: HCV Related Cirrhosis | NA | Status: TERMINATED